APA

Hsu E., Rice M. A., Bermudez A., Marques F. J. G., Aslan M., Liu S., Ghoochani A., Zhang C. A., Chen Y., Zlitni A., Kumar S., Nolley R., Habte F., Shen M., Koul K., Peehl D. M., Zoubeidi A., Gambhir S. S., Kunder C. A., Pitteri S. J., Brooks J. D. & Stoyanova T. (20200511). Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. : Proceedings of the National Academy of Sciences of the United States of America.

Chicago

Hsu En-Chi, Rice Meghan A, Bermudez Abel, Marques Fernando Jose Garcia, Aslan Merve, Liu Shiqin, Ghoochani Ali, Zhang Chiyuan Amy, Chen Yun-Sheng, Zlitni Aimen, Kumar Sahil, Nolley Rosalie, Habte Frezghi, Shen Michelle, Koul Kashyap, Peehl Donna M, Zoubeidi Amina, Gambhir Sanjiv S, Kunder Christian A, Pitteri Sharon J, Brooks James D and Stoyanova Tanya. 20200511. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. : Proceedings of the National Academy of Sciences of the United States of America.

Harvard

Hsu E., Rice M. A., Bermudez A., Marques F. J. G., Aslan M., Liu S., Ghoochani A., Zhang C. A., Chen Y., Zlitni A., Kumar S., Nolley R., Habte F., Shen M., Koul K., Peehl D. M., Zoubeidi A., Gambhir S. S., Kunder C. A., Pitteri S. J., Brooks J. D. and Stoyanova T. (20200511). Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. : Proceedings of the National Academy of Sciences of the United States of America.

MLA

Hsu En-Chi, Rice Meghan A, Bermudez Abel, Marques Fernando Jose Garcia, Aslan Merve, Liu Shiqin, Ghoochani Ali, Zhang Chiyuan Amy, Chen Yun-Sheng, Zlitni Aimen, Kumar Sahil, Nolley Rosalie, Habte Frezghi, Shen Michelle, Koul Kashyap, Peehl Donna M, Zoubeidi Amina, Gambhir Sanjiv S, Kunder Christian A, Pitteri Sharon J, Brooks James D and Stoyanova Tanya. Trop2 is a driver of metastatic prostate cancer with neuroendocrine phenotype via PARP1. : Proceedings of the National Academy of Sciences of the United States of America. 20200511.